Stockreport

BioMarin is Buying a Rare-Disease Biotech for Nearly $5 Billion. The Stock Is Jumping. [Barron's]

BioMarin Pharmaceutical Inc.  (BMRN) 
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.biomarin.com
PDF BioMarin is Buying a Rare-Disease Biotech for Nearly $5 Billion. The Stock Is Jumping. [Read more]